Literature DB >> 1721024

Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages.

F Y Liew1, Y Li, D Moss, C Parkinson, M V Rogers, S Moncada.   

Abstract

Inbred strains of mice differ considerably in their innate resistance to leishmanial infection. BALB/c mice are highly susceptible to cutaneous leishmaniasis caused by Leishmania major, whereas CBA mice are resistant. We now show that this resistance correlates with the ability of macrophages to synthesize nitric oxide (NO) following activation with interferon-gamma or tumor necrosis factor alpha. Furthermore, the larger amounts of NO generated by resistant macrophages are related to higher levels of NO synthase activity, a difference which is not attributable to the number or the affinity of the receptors for interferon-gamma on these cells. The level of NO synthesis by activated macrophages was also correlated to the resistance in a number of other inbred mouse strains tested; macrophages from the resistant B10.S, C57BL and C3H mice produced significantly higher levels of NO than the macrophages from the susceptible BALB.b and DBA/2 mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721024     DOI: 10.1002/eji.1830211216

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  64 in total

1.  Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Carol Campbell; Duncan Thomson; Mousa Komai-Koma; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

2.  Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.

Authors:  Geneviève Forget; David J Gregory; Lorie A Whitcombe; Martin Olivier
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

3.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

4.  Leishmanicidal activities of novel methylseleno-imidocarbamates.

Authors:  Celia Fernández-Rubio; Daphne Campbell; Andrés Vacas; Elena Ibañez; Esther Moreno; Socorro Espuelas; Alfonso Calvo; Juan Antonio Palop; Daniel Plano; Carmen Sanmartin; Paul A Nguewa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

5.  The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro.

Authors:  E Cillari; F Arcoleo; M Dieli; R D'Agostino; G Gromo; F Leoni; S Milano
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.

Authors:  D H Brown; J Sheridan; D Pearl; B S Zwilling
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

8.  In vitro killing of Mycobacterium ulcerans by acidified nitrite.

Authors:  R Phillips; S Kuijper; N Benjamin; M Wansbrough-Jones; M Wilks; A H J Kolk
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.

Authors:  R Phillips; O Adjei; S Lucas; N Benjamin; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages.

Authors:  A Gessner; M Vieth; A Will; K Schröppel; M Röllinghoff
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.